Cervicovaginal microbiome dynamics after taking oral probiotics.
暂无分享,去创建一个
Huijue Jia | Zhuye Jie | Huanming Yang | Jian Wang | K. Kristiansen | Xin Jin | Xin Tong | Tao Zhang | Jie Zhu | Liu Tian | Xun Xu | Lilan Hao | Zhe Zhang | L. Xiao | Chen Chen | Xiaowei Zhang
[1] Fei Gao,et al. CNGBdb: China National GeneBank DataBase. , 2020, Yi chuan = Hereditas.
[2] Michael R. Wierzbicki,et al. Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. , 2020, The New England journal of medicine.
[3] Carlos Ribeiro,et al. The diet-microbiome tango: how nutrients lead the gut brain axis , 2020, Current Opinion in Neurobiology.
[4] P. Castle,et al. Cervicovaginal microbiome and natural history of HPV in a longitudinal study , 2020, PLoS pathogens.
[5] M. V. D. van den Brink,et al. Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development. , 2020, Cell host & microbe.
[6] G. Gloor,et al. Effect of Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women , 2020, Nutrients.
[7] Fei Gao,et al. CNSA: a data repository for archiving omics data , 2020, bioRxiv.
[8] E. Elinav,et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis , 2019, Nature Medicine.
[9] Huijue Jia,et al. Life history recorded in the vagino-cervical microbiome , 2019, bioRxiv.
[10] Mary Sharpe,et al. Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[11] D. Charnock-Jones,et al. Human placenta has no microbiome but can harbour potential pathogens , 2019, Nature.
[12] H. Fu,et al. The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial , 2019, BMC women's health.
[13] Benjamin M Hillmann,et al. Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. , 2019, Cell host & microbe.
[14] Jonas Korlach,et al. The vaginal microbiome and preterm birth , 2019, Nature Medicine.
[15] W. Wade,et al. Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double‐blind, placebo‐controlled trial with microbiome analysis , 2019, BJOG : an international journal of obstetrics and gynaecology.
[16] Samantha L. van der Beek,et al. Streptococcal dTDP‐L‐rhamnose biosynthesis enzymes: functional characterization and lead compound identification , 2019, Molecular microbiology.
[17] Luke R. Thompson,et al. Species-level functional profiling of metagenomes and metatranscriptomes , 2018, Nature Methods.
[18] Huijue Jia,et al. The metagenome of the female upper reproductive tract , 2018, GigaScience.
[19] Itai Sharon,et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features , 2018, Cell.
[20] Huijue Jia,et al. A gene catalogue of the Sprague-Dawley rat gut metagenome , 2018, GigaScience.
[21] Jian Wang,et al. A novel affordable reagent for room temperature storage and transport of fecal samples for metagenomic analyses , 2018, Microbiome.
[22] Melis N. Anahtar,et al. Cervicovaginal Microbiota and Reproductive Health: The Virtue of Simplicity. , 2018, Cell host & microbe.
[23] Liying Yang,et al. HPViewer: Sensitive and specific genotyping of human papillomavirus in metagenomic DNA , 2017, bioRxiv.
[24] Huijue Jia,et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases , 2017, Nature Communications.
[25] Rob Knight,et al. Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania , 2017, Science.
[26] J. Gordon,et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells , 2017, Science.
[27] L. McKinnon,et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women , 2017, Science.
[28] G. Reid. The development of probiotics for women's health. , 2017, Canadian journal of microbiology.
[29] Melis N. Anahtar,et al. Lactobacillus‐Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women , 2017, Immunity.
[30] J. Marchesi,et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? , 2016, Microbiome.
[31] Benjamin M Hillmann,et al. Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. , 2016, Cell host & microbe.
[32] Jun Wang,et al. Metagenome-wide association studies: fine-mining the microbiome , 2016, Nature Reviews Microbiology.
[33] H. Tettelin,et al. The essential genome of Streptococcus agalactiae , 2016, BMC Genomics.
[34] R. Fichorova,et al. The Human Microbiome during Bacterial Vaginosis , 2016, Clinical Microbiology Reviews.
[35] E. Segal,et al. Personalized Nutrition by Prediction of Glycemic Responses , 2015, Cell.
[36] Duy Tin Truong,et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling , 2015, Nature Methods.
[37] Christine L. Sun,et al. Temporal and spatial variation of the human microbiota during pregnancy , 2015, Proceedings of the National Academy of Sciences.
[38] Jean M. Macklaim,et al. Changes in vaginal microbiota following antimicrobial and probiotic therapy , 2015, Microbial ecology in health and disease.
[39] A. Iwasaki,et al. Cervicovaginal microbiota: simple is better. , 2015, Immunity.
[40] G. Gloor,et al. Is There a Role for Probiotics in the Prevention of Preterm Birth? , 2015, Front. Immunol..
[41] R. Britton,et al. Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model , 2014, Journal of cellular physiology.
[42] W. Kneifel,et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery , 2014, Scientific Reports.
[43] Roberto Romero,et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women , 2014, Microbiome.
[44] R. Britton,et al. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice , 2013, Journal of cellular physiology.
[45] Jacques Ravel,et al. Vaginal microbiome: rethinking health and disease. , 2012, Annual review of microbiology.
[46] Katherine H. Huang,et al. A framework for human microbiome research , 2012, Nature.
[47] J. Marrazzo,et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. , 2012, The Journal of infectious diseases.
[48] Zaid Abdo,et al. Temporal Dynamics of the Human Vaginal Microbiota , 2012, Science Translational Medicine.
[49] R. Brotman,et al. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. , 2011, The Journal of clinical investigation.
[50] Richard M. Karp,et al. Faster and More Accurate Sequence Alignment with SNAP , 2011, ArXiv.
[51] R. Edwards,et al. Fast Identification and Removal of Sequence Contamination from Genomic and Metagenomic Datasets , 2011, PloS one.
[52] J. Habbema,et al. Lactobacillus rhamnosus GR‐1 and L. reuteri RC‐14 to prevent or cure bacterial vaginosis among women with HIV , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[53] P. Gajer,et al. Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.
[54] R. Cone,et al. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli , 2010, BMC infectious diseases.
[55] G. Reid,et al. Anti‐inflammatory effects of probiotic yogurt in inflammatory bowel disease patients , 2007, Clinical and experimental immunology.
[56] G. Reid,et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. , 2006, Microbes and infection.
[57] L. Morelli,et al. Utilization of the Intestinal Tract as a Delivery System for Urogenital Probiotics , 2004, Journal of clinical gastroenterology.
[58] G. Reid,et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. , 2003, FEMS immunology and medical microbiology.
[59] J. Yother,et al. Requirement for Capsule in Colonization byStreptococcus pneumoniae , 2001, Infection and Immunity.
[60] A. Bruce,et al. Oral probiotics can resolve urogenital infections. , 2001, FEMS immunology and medical microbiology.
[61] S. Boris,et al. Role played by lactobacilli in controlling the population of vaginal pathogens. , 2000, Microbes and infection.
[62] S. Romero-Steiner,et al. Relationship between Cell Surface Carbohydrates and Intrastrain Variation on Opsonophagocytosis ofStreptococcus pneumoniae , 1999, Infection and Immunity.
[63] Jacob M. Luber,et al. Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing , 2017 .